Accessibility Menu

Camurus Ab (publ)

(OTC) CAMRF

Current Price$58.00
Market Cap$3.45B
Since IPO (2017)+276%
5 Year+350%
1 Year-14%
1 Month-8%

Camurus Ab (publ) Financials at a Glance

Market Cap

$3.45B

Revenue (TTM)

SEK 2.23B

Net Income (TTM)

SEK 680.32M

EPS (TTM)

$1.20

P/E Ratio

47.84

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$58.00

Volume

16

Open

$59.50

Previous Close

$58.00

Daily Range

$58.00 - $59.50

52-Week Range

$55.00 - $71.00

Estimated Earnings Date

Jul 15, 2026

CAMRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Camurus Ab (publ)

Industry

Pharmaceuticals

Employees

308

CEO

Sven Fredrik Tiberg, PhD

Headquarters

Lund, 223 70, SE

CAMRF Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

37%

Net Income Margin

30%

Return on Equity

18%

Return on Capital

18%

Return on Assets

14%

Earnings Yield

2.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.45B

Shares Outstanding

59.51M

Volume

16

Avg. Volume

47.406

Financials (TTM)

Gross Profit

SEK 2.11B

Operating Income

SEK 873.93M

EBITDA

SEK 963.86M

Operating Cash Flow

SEK 869.30M

Capital Expenditure

-SEK 138.52M

Free Cash Flow

SEK 730.78M

Cash & ST Invst.

SEK 3.73B

Total Debt

SEK 106.03M

Camurus Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 531.29M

-4.8%

Gross Profit

SEK 487.40M

-6.1%

Gross Margin

91.74%

N/A

Market Cap

$3.45B

N/A

Market Cap/Employee

$14.50M

N/A

Employees

238

N/A

Net Income

SEK 143.33M

-27.3%

EBITDA

SEK 187.09M

-28.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 3.86B

+34.2%

Total Debt

SEK 109.71M

+2.9%

Accounts Receivable

SEK 620.20M

-6.8%

Inventory

SEK 116.80M

-13.0%

Long Term Debt

SEK 88.34M

+1.0%

Short Term Debt

SEK 21.37M

+11.6%

Return on Assets

13.76%

N/A

Return on Invested Capital

18.05%

N/A

Free Cash Flow

SEK 122.27M

+181.1%

Operating Cash Flow

SEK 161.62M

+108.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNPHFSanten Pharmaceutical Co., Ltd.
$10.99+0.00%
TLPPFTelix Pharmaceuticals Limited
$9.41+2.34%
AMBBYAmbu A/S
$9.79-3.69%
GLPGFGalapagos N.V.
$28.08+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$13.42-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.25+0.06%
DSYBig Tree Cloud
$7.20+2.91%
TQQQProShares Trust - ProShares UltraPro Qqq
$69.27-0.06%

Questions About CAMRF

What is the current price of Camurus Ab (publ)?

Camurus Ab (publ) is trading at $58.00 per share.

What is the 52-week range for Camurus Ab (publ)?

Over the past 52 weeks, Camurus Ab (publ) has traded between $55.00 and $71.00.

How much debt does Camurus Ab (publ) have?

As of the most recent reporting period, Camurus Ab (publ) reported total debt of SEK 11.56M.

How much cash does Camurus Ab (publ) have on hand?

Camurus Ab (publ) reported SEK 406.84M in cash and cash equivalents in its most recent financial results.

What is Camurus Ab (publ)’s dividend yield?

Camurus Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.